leading glp-1 treatments for diabetes 2025 Receptor Agonist Market Size Puerto Rico leads U.S. growth

Avoid GLP-1s if you have a multiple endocrine neoplasia syndrome type 2 (MEN2)

Offer additional support by sharing tips on diet, drinking water, and building healthy habits

We promptly initiated a review and have been in direct and ongoing communication with the patient to reach a resolution

Tertiary site: The back of the upper arm

However, not all patients respond effectively to GLP-1R monoagonists, and higher doses aimed at increasing efficacy result in adverse gastrointestinal effects

Furthermore, it can promote plaque buildup which can damage and narrow arteries and increase blood pressure, leading to increased risks for developing cardiovascular diseases such as atherosclerosis and thrombosis